florastamin
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
4
Phase 4
0
Earliest trial started Apr 28, 2021 (NCT05004285)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06754085 | Phase 3 | Dec 19, 2024 | — |
| NCT06011304 | Phase 3 | Oct 20, 2023 | — |
| NCT05936658 | Phase 3 | May 8, 2023 | FutureChem, The National Cancer Center |
| NCT05004285 | Phase 3 | Apr 28, 2021 | Catholic University of Korea, FutureChem |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| FutureChem | For profit | 2 | 2 | 1 | 2021 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2021 |
| The National Cancer Center | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1